[Mucopolysaccharidosis: clinical features, diagnosis and management].
Suarez-Guerrero JL, Gómez Higuera PJ, Arias Flórez JS, Contreras-García GA.
Rev Chil Pediatr. 2016 Jul-Aug;87(4):295-304. doi: 10.1016/j.rchipe.2015.10.004. Epub 2015 Nov 21.
[Mucopolysaccharidosis: A review].
Michaud M, Belmatoug N, Catros F, Ancellin S, Touati G, Levade T, Gaches F.
Rev Med Interne. 2020 Mar;41(3):180-188. doi: 10.1016/j.revmed.2019.11.010. Epub 2020 Jan 17.
Mucopolysaccharidosis: A broad review.
Nagpal R, Goyal RB, Priyadarshini K, Kashyap S, Sharma M, Sinha R, Sharma N.
Indian J Ophthalmol. 2022 Jul;70(7):2249-2261. doi: 10.4103/ijo.IJO_425_22.
Epidemiology of mucopolysaccharidoses.
Khan SA, Peracha H, Ballhausen D, Wiesbauer A, Rohrbach M, Gautschi M, Mason RW, Giugliani R, Suzuki Y, Orii KE, Orii T, Tomatsu S.
Mol Genet Metab. 2017 Jul;121(3):227-240. doi: 10.1016/j.ymgme.2017.05.016. Epub 2017 May 26.
Mucopolysaccharidosis III: Molecular basis and treatment.
Spahiu L, Behluli E, Peterlin B, Nefic H, Hadziselimovic R, Liehr T, Temaj G.
Pediatr Endocrinol Diabetes Metab. 2021;27(3):201-208. doi: 10.5114/pedm.2021.109270.
The mucopolysaccharidoses (a review).
Dorfman A, Matalon R.
Proc Natl Acad Sci U S A. 1976 Feb;73(2):630-7. doi: 10.1073/pnas.73.2.630.
Misdiagnosis in mucopolysaccharidoses.
Wiśniewska K, Wolski J, Gaffke L, Cyske Z, Pierzynowska K, Węgrzyn G.
J Appl Genet. 2022 Sep;63(3):475-495. doi: 10.1007/s13353-022-00703-1. Epub 2022 May 13.
Pathogenic Roles of Heparan Sulfate and Its Use as a Biomarker in Mucopolysaccharidoses.
Minami K, Morimoto H, Morioka H, Imakiire A, Kinoshita M, Yamamoto R, Hirato T, Sonoda H.
Int J Mol Sci. 2022 Oct 3;23(19):11724. doi: 10.3390/ijms231911724.
Mucopolysaccharidosis-Plus Syndrome.
Vasilev F, Sukhomyasova A, Otomo T.
Int J Mol Sci. 2020 Jan 9;21(2):421. doi: 10.3390/ijms21020421.
Mucopolysaccharidosis.
Danos O, Heard JM.
Mol Cell Biol Hum Dis Ser. 1995;5:350-67. doi: 10.1007/978-94-011-0547-7_17.
